000 | 01222 a2200313 4500 | ||
---|---|---|---|
005 | 20250518000630.0 | ||
264 | 0 | _c20190103 | |
008 | 201901s 0 0 eng d | ||
022 | _a1558-1950 | ||
024 | 7 |
_a10.1016/j.giec.2018.05.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeerhøy, Bonna | |
245 | 0 | 0 |
_aHow to Avoid Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. _h[electronic resource] |
260 |
_bGastrointestinal endoscopy clinics of North America _cOct 2018 |
||
300 |
_a439-454 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdministration, Rectal |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
650 | 0 | 4 |
_aCholangiopancreatography, Endoscopic Retrograde _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPancreatitis _xetiology |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 |
_aRinger's Lactate _xtherapeutic use |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aStents |
700 | 1 | _aElmunzer, B Joseph | |
773 | 0 |
_tGastrointestinal endoscopy clinics of North America _gvol. 28 _gno. 4 _gp. 439-454 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.giec.2018.05.007 _zAvailable from publisher's website |
999 |
_c28861309 _d28861309 |